Atlas FDA

IMPELLA LEFT VENTRICULAR SUPPORT SYSTEM

FDA premarket approval P140003/S005 · decided 2016-04-07

Approval details

PMA number
P140003
Supplement
S005
Supplement type
Panel Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
IMPELLA LEFT VENTRICULAR SUPPORT SYSTEM
Generic name
Temporary non-roller type left heart support blood pump
Applicant
Abiomed, Inc.
Date received
2015-08-13
Decision date
2016-04-07
Days to decision
238 days
Decision code
APPR
Product code
OZD
Advisory committee
Cardiovascular
Expedited review
No
Location
Danvers, MA
Statement
Approval for the Impella 2.5, Impella CP, Impella 5.0, and Impella LD catheters, in conjunction with the Automated Impella Controller, are temporary ventricular support devices intended for short term use (<= 4 days for the Impella 2.5 and Impella CP, and <=6 days for Impella 5.0 and LD) and indicated for the treatment of ongoing cardiogenic shock that occurs immediately (<48 hours) following acute myocardial infarction or open heart surgery as a result of isolated left ventricular failure that

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
14Fr Low Profile Introducer Kit (K252766)Abiomed, Inc.2025-10-08
Abiomed 14Fr Low Profile Introducer Kit (K241708)Abiomed, Inc.2024-08-06
preCARDIA Occlusion System (K221294)Abiomed, Inc.2023-06-30
OXY-1 System (K223161)Abiomed, Inc.2023-02-23
Abiomed 14Fr Low Profile Introducer Set (K222113)Abiomed, Inc.2022-10-13
Impella XR Sheath Set (K202330)Abiomed, Inc.2020-12-07
OXY-1 System (K200109)Abiomed, Inc.2020-10-23
Abiomed 23 Fr Sheath (K201116)Abiomed, Inc.2020-06-15